Bohai Pharmaceuticals Publishes Annual Letter to Shareholders.

Extract


Bohai Pharmaceuticals Publishes Annual Letter to Shareholders.

Chairman & CEO Updates Shareholders, Speaks to Recently Expanded TCM Portfolio and Growth Initiatives for 2011

YANTAI, China -- Bohai Pharmaceuticals Group, Inc. (OTCBB/OTCQB: BOPH), a China-based pharmaceutical company engaged in the production, manufacturing and distribution of Traditional Chinese Medicine (TCM) in China, today published a letter to shareholders from Hongwei Qu, Bohai's Chairman, President and Chief Executive Officer, providing investors with management's year-end summary for 2010 and vision for 2011.

Dear Shareholders:

It is my pleasure to discuss Bohai's various corporate developments to date, as well as our plans for the future as we en...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company